Narrowing the gap on total cold chain visibility through the power of real-time temperature monitoring
By World Courier
For much of the past two decades, the way pharmaceutical shipments were monitored changed very little. Times are changing...
Temperature loggers evolved from paper chart recorders to small digital devices, but the underlying process remained largely the same: a monitor was placed inside the shipment, and temperature data was only reviewed after the shipment arrived.
In today’s pharmaceutical supply chains, that model is rapidly becoming outdated.
The rise of complex biologics, advanced therapies, and high-value medicines has dramatically increased the stakes for temperature-controlled logistics. As supply chains become more global, more regulated and more patient-critical, pharmaceutical companies are placing far greater emphasis on visibility during transit rather than after delivery.¹
Increasingly, the expectation is simple: if something goes wrong in transit, teams should know immediately — not hours or days later.
According to Michael Culme-Seymour, Regional Vice President for Asia Pacific at World Courier, shipment monitoring historically evolved slowly.
“When I joined the industry around 25 years ago, we were still using what were essentially paper-based temperature monitors,” he explains. “A roll of paper inside a device would draw a line showing the temperature over time. When the shipment arrived, someone would retrieve the monitor and check the chart.”
Digital loggers eventually replaced paper charts, but the overall process remained largely unchanged. Even the more modern USB-enabled loggers still relied on manual retrieval and data download at the end of the journey.
“The fundamental limitation was that you only saw the temperature history after the shipment arrived,” says Michael. “If there had been a temperature deviation during transit, you discovered it once the shipment was already delivered.”
For pharmaceutical companies moving temperature-sensitive products across global networks, that retrospective model increasingly creates operational challenges.²
The pressure for greater shipment visibility is being driven by several structural changes in the pharmaceutical industry.
First, the value of individual therapies has increased dramatically. Many biologics and specialty medicines now carry higher operational and financial risk per shipment, increasing the need for visibility and control.³
Second, the industry is seeing rapid growth in advanced therapies such as cell and gene therapies (CGTs). In some cases, these treatments are manufactured using a patient’s own cells, creating highly individualized medicines.
“In some scenarios you’re transporting a therapy that is effectively irreplaceable,” says Michael. “You’re not just shipping a pharmaceutical product — you’re transporting something that has been manufactured specifically for a single patient.”
Finally, many modern therapies are biologically derived and highly temperature-sensitive, requiring strict control across complex international logistics networks.⁴
These trends are raising expectations across the pharmaceutical supply chain.
“Customers are under constant pressure to reduce risk and control costs,” says Michael. “Real-time temperature monitoring helps address both.”
External research has also highlighted how supply chain visibility is becoming a critical priority for pharmaceutical companies seeking to improve resilience, compliance and operational control.¹
A major step forward came in 2023 with the introduction of real-time location monitoring (RTLM) for controlled ambient, refrigerated and frozen shipments, therefore allowing logistics teams to track the precise location of shipments throughout their journeys.
This innovation addressed a long-standing challenge in pharmaceutical logistics: once shipments entered airline networks or transit hubs, visibility was often limited.
“With real-time location monitoring, we can see exactly where a shipment is anywhere in the world bar a handful of countries,” says Michael. “If something is delayed or misplaced, we can help partners locate it much faster.”
Real-time temperature monitoring (RTTM) builds on that capability by extending visibility inside the shipment itself.
Instead of relying on passive loggers that record temperature for later review, RTTM devices provide real-time visibility into temperature conditions during transit. This allows logistics teams to observe environmental conditions while shipments are still moving through the network.
For the first time at scale, temperature monitoring shifts from retrospective validation to active operational oversight.²
In today’s pharmaceutical supply chains, that model is rapidly becoming outdated.
The rise of complex biologics, advanced therapies, and high-value medicines has dramatically increased the stakes for temperature-controlled logistics. As supply chains become more global, more regulated and more patient-critical, pharmaceutical companies are placing far greater emphasis on visibility during transit rather than after delivery.¹
Increasingly, the expectation is simple: if something goes wrong in transit, teams should know immediately — not hours or days later.
Monitoring technology has stood still for decades
According to Michael Culme-Seymour, Regional Vice President for Asia Pacific at World Courier, shipment monitoring historically evolved slowly.
“When I joined the industry around 25 years ago, we were still using what were essentially paper-based temperature monitors,” he explains. “A roll of paper inside a device would draw a line showing the temperature over time. When the shipment arrived, someone would retrieve the monitor and check the chart.”
Digital loggers eventually replaced paper charts, but the overall process remained largely unchanged. Even the more modern USB-enabled loggers still relied on manual retrieval and data download at the end of the journey.
“The fundamental limitation was that you only saw the temperature history after the shipment arrived,” says Michael. “If there had been a temperature deviation during transit, you discovered it once the shipment was already delivered.”
For pharmaceutical companies moving temperature-sensitive products across global networks, that retrospective model increasingly creates operational challenges.²
Why visibility matters more than ever
The pressure for greater shipment visibility is being driven by several structural changes in the pharmaceutical industry.
First, the value of individual therapies has increased dramatically. Many biologics and specialty medicines now carry higher operational and financial risk per shipment, increasing the need for visibility and control.³
Second, the industry is seeing rapid growth in advanced therapies such as cell and gene therapies (CGTs). In some cases, these treatments are manufactured using a patient’s own cells, creating highly individualized medicines.
“In some scenarios you’re transporting a therapy that is effectively irreplaceable,” says Michael. “You’re not just shipping a pharmaceutical product — you’re transporting something that has been manufactured specifically for a single patient.”
Finally, many modern therapies are biologically derived and highly temperature-sensitive, requiring strict control across complex international logistics networks.⁴
These trends are raising expectations across the pharmaceutical supply chain.
“Customers are under constant pressure to reduce risk and control costs,” says Michael. “Real-time temperature monitoring helps address both.”
External research has also highlighted how supply chain visibility is becoming a critical priority for pharmaceutical companies seeking to improve resilience, compliance and operational control.¹
The shift from retrospective logging to real-time monitoring
A major step forward came in 2023 with the introduction of real-time location monitoring (RTLM) for controlled ambient, refrigerated and frozen shipments, therefore allowing logistics teams to track the precise location of shipments throughout their journeys.
This innovation addressed a long-standing challenge in pharmaceutical logistics: once shipments entered airline networks or transit hubs, visibility was often limited.
“With real-time location monitoring, we can see exactly where a shipment is anywhere in the world bar a handful of countries,” says Michael. “If something is delayed or misplaced, we can help partners locate it much faster.”
Real-time temperature monitoring (RTTM) builds on that capability by extending visibility inside the shipment itself.
Instead of relying on passive loggers that record temperature for later review, RTTM devices provide real-time visibility into temperature conditions during transit. This allows logistics teams to observe environmental conditions while shipments are still moving through the network.
For the first time at scale, temperature monitoring shifts from retrospective validation to active operational oversight.²
Turning data into operational action
Real-time data alone is not enough to improve cold chain performance. To manage large global networks, logistics providers must also be able to interpret and act on the data generated by thousands of shipments simultaneously.
This is where centralized monitoring systems such as World Courier’s Digital Control Tower play an important role.
Despite the name, the system is not a physical command center but rather a software platform that continuously monitors shipment data and applies automated rules to identify potential risks.
What our experts say:
When you have thousands of consignments moving through the network, it’s impossible for people to manually monitor every shipment. The Digital Control Tower applies a set of rules that alerts our teams when something looks like it may become a problem.
Michael Culme-Seymour
Regional Vice President, Asia Pacific, World Courier
“When you have thousands of consignments moving through the network, it’s impossible for people to manually monitor every shipment,” Michael explains. “The Digital Control Tower applies a set of rules that alerts our teams when something looks like it may become a problem.”
For example, if temperature data shows a shipment trending toward a potential deviation, the system can alert operational teams to investigate and intervene where possible.
This kind of real-time monitoring helps logistics teams identify potential disruptions earlier and respond before they escalate into larger operational problems.⁵
In practice, the ability to intervene early can make a significant difference.
Consider a shipment moving between two international locations via an airline hub. If the shipment is mistakenly stored in the wrong temperature environment during a layover, temperature conditions inside the packaging may begin trending toward a deviation.
With traditional passive logging, that issue would only become visible after the shipment was delivered and the temperature logger was downloaded.
With real-time monitoring, however, the change in temperature trend can be detected during transit.
“Because World Courier operates a global network with standardized packaging and operational teams in multiple regions, our local teams can sometimes intervene where possible — for example by accessing the shipment and replenishing phase-change cooling materials inside the packaging,” says Michael.
While not every situation allows for intervention, early visibility significantly increases the likelihood of preventing temperature excursions.
One of the most important operational benefits of real-time monitoring occurs after the shipment arrives.
With traditional data loggers, temperature data typically becomes available only once the device is retrieved and downloaded. Quality Assurance teams must then review the data before confirming that the product remains within specification.
This process can introduce delays between delivery and product release.²
Real-time temperature monitoring changes this dynamic.
Because shipment data is continuously transmitted and automatically recorded, compliance documentation can be generated within one hour of delivery once the shipment reaches its destination. Temperature history is already available to the shipper, consignee, and third parties designated at shipment initiation when no temperature excursion occurs.
“This allows quality teams to review shipment conditions much faster and reduces delays before therapies can be released for use,” says Michael.
He adds: “For time-sensitive medicines — particularly advanced therapies destined for individual patients — even small reductions in release delays can be meaningful.”
The growing adoption of RTTM reflects a broader shift toward digital supply chains across the pharmaceutical industry.
Consumers today can track everyday parcel deliveries in real time through mobile apps. Increasingly, pharmaceutical companies expect a similar level of transparency for their most critical shipments.
“People’s expectations around visibility are changing,” says Michael. “It’s another step toward building a fully transparent digital supply chain.”
RTTM represents a key part of that evolution. As pharmaceutical products become more valuable, more complex and more patient-specific, the ability to monitor and manage shipments proactively is likely to become the new standard rather than a specialized capability.
Ultimately, the goal is not simply better logistics performance — but greater confidence that life-saving therapies reach the patients who need them, exactly as intended.
For example, if temperature data shows a shipment trending toward a potential deviation, the system can alert operational teams to investigate and intervene where possible.
This kind of real-time monitoring helps logistics teams identify potential disruptions earlier and respond before they escalate into larger operational problems.⁵
A practical example: preventing temperature excursions
In practice, the ability to intervene early can make a significant difference.
Consider a shipment moving between two international locations via an airline hub. If the shipment is mistakenly stored in the wrong temperature environment during a layover, temperature conditions inside the packaging may begin trending toward a deviation.
With traditional passive logging, that issue would only become visible after the shipment was delivered and the temperature logger was downloaded.
With real-time monitoring, however, the change in temperature trend can be detected during transit.
“Because World Courier operates a global network with standardized packaging and operational teams in multiple regions, our local teams can sometimes intervene where possible — for example by accessing the shipment and replenishing phase-change cooling materials inside the packaging,” says Michael.
While not every situation allows for intervention, early visibility significantly increases the likelihood of preventing temperature excursions.
Faster compliance decisions after delivery
One of the most important operational benefits of real-time monitoring occurs after the shipment arrives.
With traditional data loggers, temperature data typically becomes available only once the device is retrieved and downloaded. Quality Assurance teams must then review the data before confirming that the product remains within specification.
This process can introduce delays between delivery and product release.²
Real-time temperature monitoring changes this dynamic.
Because shipment data is continuously transmitted and automatically recorded, compliance documentation can be generated within one hour of delivery once the shipment reaches its destination. Temperature history is already available to the shipper, consignee, and third parties designated at shipment initiation when no temperature excursion occurs.
“This allows quality teams to review shipment conditions much faster and reduces delays before therapies can be released for use,” says Michael.
He adds: “For time-sensitive medicines — particularly advanced therapies destined for individual patients — even small reductions in release delays can be meaningful.”
Towards a transparent digital supply chain
The growing adoption of RTTM reflects a broader shift toward digital supply chains across the pharmaceutical industry.
Consumers today can track everyday parcel deliveries in real time through mobile apps. Increasingly, pharmaceutical companies expect a similar level of transparency for their most critical shipments.
“People’s expectations around visibility are changing,” says Michael. “It’s another step toward building a fully transparent digital supply chain.”
RTTM represents a key part of that evolution. As pharmaceutical products become more valuable, more complex and more patient-specific, the ability to monitor and manage shipments proactively is likely to become the new standard rather than a specialized capability.
Ultimately, the goal is not simply better logistics performance — but greater confidence that life-saving therapies reach the patients who need them, exactly as intended.
References
- Economist Impact. Across the Procurement-Verse: Changing Trends in the Procurement Function. Economist Impact, 2023. https://impact.economist.com/projects/the-procurement-imperative/pdfs/across-the-procurement-verse-changing-trends-in-the-procurement-function-global-paper-report.pdf
- IATA. Temperature Control Regulations (TCR) https://www.iata.org/en/publications/manuals/temperature-control-regulations
- Deloitte. Digitalized supply chains are essential to biopharma’s future. https://www.deloitte.com/us/en/insights/industry/health-care/end-to-end-digitalization-of-biopharma-supply-chain.html
- McKinsey & Company. McKinsey insights on cell and gene therapy: https://www.mckinsey.com/industries/life-sciences/our-insights/mckinsey-insights-on-cell-and-gene-therapy
- Deloitte. Biopharma digital transformation. https://www.deloitte.com/us/en/insights/industry/life-sciences/biopharma-digital-transformation.html
Topics:
Temperature control
